Tonometry in all patients is the best way to prevent blindness

Article

It is more cost-effective to perform routine tonometry in all initial ophthalmic patients than in none at all or in just high-risk glaucoma patients, according to a paper published in the March 2008 issue of Eye.

It is more cost-effective to perform routine tonometry in all initial ophthalmic patients than in none at all or in just high-risk glaucoma patients, according to a paper published in the March 2008 issue of Eye.

Using the A. Markov cost-effectiveness simulation model, A. Peeters and colleagues at Maastricht University Hospital, the Netherlands, analyzed and compared three case-finding strategies, measuring cost, proportion of patients becoming blind and years of blindness. The aim of the study was to determine the most cost-effective route for an ophthalmologist to detect and treat ocular hypertension (OH) and primary open-angle glaucoma (POAG) early in order to prevent blindness.

In the study, all patients underwent ophthalmoscopy, but tonometry was routinely performed to: (1) all initial patients, (2) high-risk patients only, or (3) no one. The population characteristics were based on data of 1000 initial patients, and transition probabilities were taken from the literature. The time-horizon of the model was 20 years, using an annual discount rate of 4%.

The researchers found that the costliest strategy - performing tonometry on all initial patients - led to least blindness. The incremental cost-effectiveness ratio, which shows extra costs per year of vision saved in comparison to the cheapest strategy (performing tonometry on no one), was found to be lower for performing tonometry on all initial patients than for performing it solely on high-risk patients. According to the study, it amounts to €1707, not including extra costs due to blindness (such as those associated with the use of disability facilities). When such costs exceed €1707 per patient per year, which is most likely, the first strategy (of performing tonometry on all initial patients) becomes cost saving.

From these results, the study concluded that the most cost-effective method of preventing blindness due to glaucoma is to routinely perform tonometry for all initial ophthalmic patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.